Sphera Funds Management Ltd. Regenxbio Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $3.04 Million - $4.86 Million	-95,564 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $4.01 Million - $5.67 Million	95,564 New	95,564 $0
Q2 2018 Aug 13, 2018	SELL	$27.2 - $74.35 $2.72 Million - $7.43 Million	-100,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$24.05 - $37.5 $1.87 Million - $2.92 Million	77,893 Added 352.35%	100,000 $2.99 Million
Q4 2017 Feb 12, 2018	BUY	$26.0 - $34.6 $574,782 - $764,902	22,107	22,107 $735,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.